SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Meridian Bioscience, Inc. (VIVO)

NEW YORK, May 30, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meridian Bioscience, Inc. ("Meridian" or the "Company") VIVO. Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/vivo.  

The investigation concerns whether Meridian and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On May 17, 2017, the U.S. Food & Drug Administration ("FDA") warned Meridian that the Company's subsidiary, Magellan Diagnostics' lead tests may be incorrect. The FDA said that tests performed on blood drawn from a vein has led to "results that are lower than the actual level of lead in the blood," and advised the discontinuation of Magellan when testing with venous blood samples. Following this news was announced, Meridian stock dropped in value.

If you are aware of any facts relating to this investigation, or purchased shares of Meridian, you can assist this investigation by visiting the firm's site: www.bgandg.com/vivo. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-meridian-bioscience-inc-vivo-300465774.html

SOURCE Bronstein, Gewirtz & Grossman, LLC